Cancer Research  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 42, 1368-1373, April 1, 1982]
© 1982 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dillman, R. O.
Right arrow Articles by Royston, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dillman, R. O.
Right arrow Articles by Royston, I.

Establishment and Characterization of an Epstein-Barr Virus-negative Lymphoma B-Cell Line from a Patient with a Diffuse Large Cell Lymphoma1

Robert O. Dillman, Harold H. Handley and Ivor Royston2

Division of Hematology/Oncology, Department of Medicine, University of California, San Diego, School of Medicine, and Veterans Administration Medical Center, La Jolla, California 92093

Cell line (LNPL) was established from a tumor biopsy of a nasopharyngeal "histiocytic" lymphoma composed of large noncleaved B-cells. LNPL expressed immunoglobulin M {kappa} surface immunoglobulin, as did the original tumor. LNPL also expressed la antigen but lacked Epstein-Barr virus nuclear antigen. It exhibited a translocation between chromosomes 8 and 14 which has been described in certain other malignant lymphoproliferative disorders. An autologous T-cell line lacked the translocation between chromosomes 8 and 14. LNPL is being used as an immunogen to produce monoclonal antibodies in our laboratory. Such cell lines may facilitate identification of lymphoma-associated surface antigens.

1 Supported by the Veterans Administration, Grant IM 207 of the American Cancer Society, Contract N01-CB-84250-31 of the National Cancer Institute, and NIH Grant PHSHL-07107-05.

2 To whom requests for reprints should be addressed, at Division of Hematology/Oncology—V111E, University of California, San Diego, School of Medicine, La Jolla, Calif. 92093.

Received 3/17/81. Accepted 1/ 4/82.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1982 by the American Association for Cancer Research.